AJANTA PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 5.9%
Fri, 3 May

AJANTA PHARMA has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:

AJANTA PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-18*
3
Dec-18*
3
Mar-19*
QoQ ChangeYoY Change
Net SalesRs m5,3034,8515,1526.2%-2.9%
Other incomeRs m524416-63.0%-68.9%
TurnoverRs m5,3564,8955,1685.6%-3.5%
ExpensesRs m3,9083,7783,8812.7%-0.7%
Gross profitRs m1,3951,0731,27118.4%-8.9%
DepreciationRs m1661871880.4%12.7%
InterestRs m118755.6%600.0%
Profit before taxRs m1,2809301,09217.5%-14.7%
TaxRs m335261203-22.1%-39.5%
Profit after taxRs m94566988932.9%-5.9%
Gross profit margin%26.322.124.7
Effective tax rate%26.228.018.6
Net profit margin%17.613.717.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 2.9% on a year-on-year (YoY) basis. The expenses were down by 0.7% YoY during the same period.
  • The company's operating profit declined by 8.9% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 24.7% in 4QFY19 as against 26.3% in 4QFY18.
  • Depreciation charges increased by 12.7% and finance costs increased by 600.0% YoY, respectively.
  • Other income declined by 68.9% YoY during the quarter.
  • Net profit for the quarter declined by 5.9% YoY. Net profit margins during the quarter declined from 17.6% in 4QFY18 to 17.2% in 4QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 6.2% on a quarter-on-quarter (QoQ) basis. The expenses were up by 2.7% QoQ during the same period.
  • The company's operating profit increased by 18.4% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 24.7% in 4QFY19 as against 22.1% in 3QFY18.
  • Net profit for the quarter increased by 32.9% QoQ, while net profit margins increased from 13.7% in 3QFY18 to 17.2% in 4QFY19.

To see how AJANTA PHARMA has performed over the last eight quarters, please visit here.

AJANTA PHARMA Share Price Performance

Over the last one year, AJANTA PHARMA share price has moved up from Rs 1,266.5 to Rs 1,048.5, registering a Loss of Rs 218.1 or around 17.2%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,158.1 (down 0.7%). Over the last one year it has moved up from 13,991.6 to 14,158.1, a gain of 166 points (up 1.2%).

Overall, the S&P BSE SENSEX is up 10.8% over the year.

Current Valuations

At the current price of Rs 1,048.5, the price to earnings (P/E) ratio of AJANTA PHARMA stands at 23.8 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 4.5 times.